These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 14196240)

  • 21. THE IMPORTANCE OF LIPID-SOLUBILITY FOR THE CENTRAL ACTION OF CHOLINOLYTIC DRUGS.
    HERZ A; TESCHEMACHER H; HOFSTETTER A; KURZ H
    Int J Neuropharmacol; 1965 Jul; 4():207-18. PubMed ID: 14343875
    [No Abstract]   [Full Text] [Related]  

  • 22. [POTENTIATED MAGNESIC EFFECT WITH AMINAZIN AND DIPHENYLACETIC ACID DERIVATIVES].
    SHITOV EE
    Farmakol Toksikol; 1964; 27():272-4. PubMed ID: 14238781
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE PROBLEM OF THE AUTONOMIC INNERVATION OF THE URINARY BLADDER. ISOLATED RAT AND MOUSE URINARY BLADDER WITH AUTONOMIC NERVES AS A MODEL FOR PHARMACOLOGICAL TESTS].
    HUKOVIC S; BUBIC I
    Acta Med Iugosl; 1963; 17():279-99. PubMed ID: 14182418
    [No Abstract]   [Full Text] [Related]  

  • 24. RELATIONSHIP BETWEEN CHOLINERGIC DRUGS AND EEG ACTIVATION.
    WHITE RP
    Arch Int Pharmacodyn Ther; 1963 Sep; 145():1-17. PubMed ID: 14077683
    [No Abstract]   [Full Text] [Related]  

  • 25. AMITRIPTYLINE AND NORTRIPTYLINE AS ANTAGONISTS OF CENTRAL AND PERIPHERAL CHOLINERGIC ACTIVATION.
    RATHBUN RC; SLATER IH
    Psychopharmacologia; 1963 Apr; 4():114-25. PubMed ID: 14050417
    [No Abstract]   [Full Text] [Related]  

  • 26. COMPARATIVE PHARMACOLOGY OF ATROPINE SULFATE, BENZTROPINE METHANESULFONATE AND ETHYLBENZTROPINE BROMIDE.
    HALEY TJ; FLESHER AM; KOMESU N; LEE E
    Arch Int Pharmacodyn Ther; 1963 Aug; 144():555-62. PubMed ID: 14060875
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological study of 2-ethyl-4-ethylamino-6-methoxy-s-triazine, a new compound with both central sympathetic and parasympathetic stimulating properties.
    Chiba S; Saji Y; Hibino H; Takeo Y; Yui T
    Arzneimittelforschung; 1968 Mar; 18(3):303-9. PubMed ID: 4386816
    [No Abstract]   [Full Text] [Related]  

  • 28. [To the pharmacology of ditran].
    Baryshnikov II; Blagovidoca LL; Mil'shteĭn GI
    Farmakol Toksikol; 1968; 31(4):434-6. PubMed ID: 5725213
    [No Abstract]   [Full Text] [Related]  

  • 29. [ON THE STATUS OF THE CENTRAL M-CHOLINOREACTIVE SYSTEM IN CO-60 IRRADIATED MICE].
    OVAKIMOV VG; IARMONENKO SP; IVANOV VN
    Radiobiologiia; 1964; 4():414-8. PubMed ID: 14189212
    [No Abstract]   [Full Text] [Related]  

  • 30. EVIDENCE INDICATING CENTRAL ATROPINE-LIKE ACTIONS OF PSYCHOTOGENIC PIPERIDYL BENZILATES.
    WHITE RP; CARLTON RA
    Psychopharmacologia; 1963 Aug; 4():459-71. PubMed ID: 14048567
    [No Abstract]   [Full Text] [Related]  

  • 31. [Central and peripheral effects of cholinomimetics and their dependence on lipoid solubility].
    Herz A; Holzhäuser H; Teschemacher H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1966; 253(2):280-97. PubMed ID: 4222746
    [No Abstract]   [Full Text] [Related]  

  • 32. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
    Ringdahl B; Jenden DJ
    J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Central effects of cholinomimetic and cholinolytic substances].
    Holmstedt B
    Actual Pharmacol (Paris); 1970; 23():175-98. PubMed ID: 4948985
    [No Abstract]   [Full Text] [Related]  

  • 34. [CONDITIONED REFLEX BRADYCARDIA IN THE RABBIT].
    RUCKEBUSCH Y; BELLANGEON M
    C R Seances Soc Biol Fil; 1963 Aug; 157():838-40. PubMed ID: 14081744
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of cholinergic substances on brain potentials induced by tooth pulp stimulation].
    Degtiarev VP
    Farmakol Toksikol; 1977; 40(2):141-6. PubMed ID: 15860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VISUALLY EVOKED RESPONSES IN MAN: A METHOD FOR MEASURING CEREBRAL EFFECTS OF PREANESTHETIC MEDICATION.
    CORSSEN G; DOMINO EF
    Anesthesiology; 1964; 25():330-41. PubMed ID: 14156574
    [No Abstract]   [Full Text] [Related]  

  • 37. [AN ANALYSIS OF CENTRAL-ACTING DRUGS USING ANIMAL EXPERIMENTS-ASSOCIATION AND DISSOCIATION BETWEEN EEG AND BEHAVIOR].
    YAMAMOTO K; KIDO R
    No To Shinkei; 1964 Jan; 16():44-58. PubMed ID: 14111590
    [No Abstract]   [Full Text] [Related]  

  • 38. [Importance of some aspects of the type of higher nervous activity in regulation of the trophic phase of the salivation reflex].
    FUGOL' OM
    Fiziol Zh; 1963; 9(1)():27-33. PubMed ID: 13960069
    [No Abstract]   [Full Text] [Related]  

  • 39. Oxybutynin--a musculotropic antispasmodic drug with moderate anticholinergic action.
    Lish PM; Labudde JA; Peters EL; Robbins SI
    Arch Int Pharmacodyn Ther; 1965 Aug; 156(2):467-88. PubMed ID: 4380481
    [No Abstract]   [Full Text] [Related]  

  • 40. Dualism in the effect of cholinolytics upon the human parotid gland deprived of parasympathetic control.
    Levin SL
    Int J Clin Pharmacol Res; 1986; 6(5):429-39. PubMed ID: 3781706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.